1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. Consensus
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
1.090 USD   +9.00%
05/16PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/13PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
BU
05/12PAVMED INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on PAVMED INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) PAVMED INC.
Analyst Recommendations on PAVMED INC.
03/30Cantor Fitzgerald Adjusts PAVmed's Price Target to $5 from $6, Keeps Overweight Rating
MT
2021PAVMED : Cantor Fitzgerald Starts PAVmed at Overweight With $8 Price Target
MT
2020PAVMED : Ascendiant Capital Starts PAVmed at Buy With $5 Price Target
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1,09 $
Average target price 6,13 $
Spread / Average Target 462%
High Price Target 9,50 $
Spread / Highest target 772%
Low Price Target 3,00 $
Spread / Lowest Target 175%
Consensus detail
Consensus revision (last 18 months)